tradingkey.logo
tradingkey.logo
Search

Connect Biopharma Holdings Ltd

CNTB
Add to Watchlist
0.677USD
+0.012+1.80%
Close 11-13 16:00(ET)
37.72MMarket Cap
LossP/E TTM

Connect Biopharma Holdings Ltd (CNTB) Stock Price Target & Forecast

Analyst Rating

Based on 8 analysts giving stock ratings to Connect Biopharma Holdings Ltd in the past month.

Buy
3 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
6.000USD+647.94%

CNTB Analyst Recommendation Trends

In the current month, CNTB has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CNTB average Analyst price target in the last month is 6.000.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
3
3
3
2
2
2
2
2
Buy
5
5
5
5
5
3
3
3
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
8
8
8
7
7
5
5
5

CNTB Analyst Rating for Peer Comparison

Updated: Nov 5, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22

Financial Forecasting

Based on analysts' estimates, CNTB EPS is projected to reach -0.040 in FY2026Q3, following reported EPS of -0.275 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.03
-0.03
-0.05
-0.04
-0.03
Actual
-0.27
-0.34
-0.27
--
--
Surprise
-781.60%
-931.08%
-482.04%
--
--

FAQs

What is Connect Biopharma Holdings Ltd's expected revenue for the next quarter?

Connect Biopharma Holdings Ltd's expected revenue is 115.65K.

What is Connect Biopharma Holdings Ltd's price target?

Analysts forecast that Connect Biopharma Holdings Ltd's price target is USD 6.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 4.00.

How have Connect Biopharma Holdings LtdCNTB's recent earnings per share performed?

The market expectation was USD -0.27, while Connect Biopharma Holdings LtdCNTB's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.04.

What is the analyst rating for Connect Biopharma Holdings Ltd?

Based on the ratings of Connect Biopharma Holdings Ltd's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.